Theme: Advance Research of Respirology and Chest

Pulmonology Congress 2020

Pulmonology Congress 2020

Asia Pacific Conferences heartily welcomes you to the most prestigious International Congress and Expo on Pulmonology during October 19-20, 2020 Manila, Philippines. The pulmonology Conference is based on the theme “Advance Research of Respirology and Chest’’

Conference welcomes pulmonology and Respiratory specialists across the globe to discuss current trends in respiratory disease screening to diagnosis, treatment and management .strategic sessions of the pulmonary & Respiratory covering about almost all of the pulmonology  Diseases such as COPD, Asthma, Allergy, Cystic fibrosis, pneumonia, tuberculosis, emphysema, Lung nodules, chronic cough ,mycobacterial infection ,influenza ,Bronchiectasis, etc.

The pulmonology congress conference  composed of well –organized scientific sessions ,plenary sessions, oral presentation, poster presentation , one to one meetings ,networking sessions, e-poster presentation ,young Research Forums ,B2B meetings ,international workshops ,symposiums, Industrial  sessions, Exhibitor presentation etc.

Who Should Attend?

Pulmonology congress 2020 welcomes the multidisciplinary medical professionals, clinicians, and researchers associated with the diagnosis, treatment associated with the diagnosis, treatment and management of respiratory diseases and allied fields. This pulmonology congress is the best platform that would help the pulmonologists and Respiratory care professionals to get the insights and latest trends to improve the patient care. All the researchers working in the field of Pulmonology, Respiratory Medicine, Asthma, Pneumonia, emphysema, tuberculosis, COPD, lungs diseases, Lung Cancer, complicated chest infections and other allied fields will be of interest. The Scope of this Pulmonology Conference is for the below professionals, but not limited to:

  • Pulmonologists
  • Respiratory medicine
  • Respiratory physicians
  • Respiratory disease specialists
  • Allergy and Immunology
  • General Medicine & Internal Medicine
  • Respiratory Therapy
  • Radiology & Radiotherapy
  • Physiotherapy
  • Nursing
  • Behavioral Science
  • Environmental and Occupational Health
  • Infectious Disease
  • Pediatric Pulmonary, Critical Care and Sleep
  • Cardiology

By attending the Pulmonology congress 2020, Manila, Philippines can get the insights of:

  • Recent trends & techniques of pulmonology medicine
  • Upgrade yourself with latest innovations to optimize the treatment process of pulmonology Diseases
  • Discuss the current challenges & update with future opportunities in improving respiratory care in future era
  • Assess the treatment gaps of various pulmonary & Respiratory diseases
  • Update yourself with new strategies of diagnosing Sleep Apnea, Asthma, Allergy, COPD and other related diseases and define the new treatment strategies
  • Review the efficacy of spirometer access of breathing partten and to identify various disease conditions like Asthma, COPD, pulmonary fibrosis, cystic fibrosis and to optimize the non-invasive mechanical ventilation process in case of respiratory failure.

Abstract Eligibility Criteria

AUTHOR ELIGIBILITY:

  • Individuals may submit up to two regular abstracts as the first author.
  • Individuals may submit an unlimited number of Trials in Progress abstracts.
  • Individuals may serve as a co-author on an unlimited number of abstracts.

ABSTRACT ELIGIBILITY

  • All types of Pulmonologists, Thoracic Surgeon’s, Medicinal, Health research are eligible for submission.
  • Abstract should address scientific questions, detail clinical observations, or contain primary scientific data.
  • Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown.
  • Interim analysis of a prospective randomized clinical trial will be considered if it is performed as planned in the original protocol and is statistically valid.
  • Abstracts of clinically-related subjects should be combined into a single abstract.

Note: Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts.

Submission Requirements:

Provide your full name, academic degree(s), institution, address, and email address and recent photograph. You will receive all future correspondence from us regarding the status of your abstract.

The selected abstracts will be published in Conference Proceedings.

Important Dates:

Early Bird Discount Registration Offer: On/Before January 30, 2020

Early Bird Abstract Submission Date: February 25, 2019

Abstract Submission Deadline: March 15, 2020

Speaker Presentations Sessions and Time limits:

Keynote Speech 40-45 Minutes,

Workshop/Symposium 60 Minutes

Plenary Speech 20-25 Minutes,

Poster Presentation 10-15 Minutes

 

Track 1:Pulmonary rehabilitation

Pulmonary rehabilitation additionally called respiratory restoration is an expansive program that improves the prosperity of individuals who have ceaseless breathing issues. For instance, aspiratory recovery may profit individuals who have COPD (endless obstructive pneumonic infection), sarcoidosis idiopathic pneumonic fibrosis, or cystic fibrosis. Pulmonary restoration additionally can profit individuals who need lung medical procedures, both when the medical procedure. Aspiratory recovery doesn't supplant therapeutic treatment.  

Pulmonary rehabilitation includes a long-haul responsibility from the patient and a group of human services suppliers. The Pulmonary restoration group may incorporate specialists, attendants, and masters. Instances of masters incorporate respiratory specialists, physical and word-related advisors, dieticians or nutritionists, and analysts or social laborers. Pneumonic restoration frequently is an outpatient program situated in a medical clinic or facility

Track 2:Genetics of Lung Disorders

Lung illness alludes to many kinds of sicknesses or issues that keep the lungs from working appropriately. Lung infection can influence respiratory capacity or the capacity to inhale, just as lung work, which is the way well the lungs work. There are numerous different lung sicknesses, a few of which are brought about by bacterial, viral, or parasitic diseases. Other lung sicknesses are identified with ecological elements, including asthma, mesothelioma, and carcinoma. The persistent lower respiratory ailment might be an assortment of conditions that has constant obstructive pneumonic sickness (COPD), emphysema, and bronchitis. Together, persistent lower respiratory illness is the main source of death in the United States. In other lung conditions, like lung fibrosis, scarring of the lung tissue, which can be brought about by different elements, and pneumonia, a bacterial or viral disease wherein the air sacs load up with liquid, the lungs have a decreased capacity to hold air. Cellular breakdown in the lungs might be a sickness brought about by strange cell development. Albeit most instances of cellular breakdown in the lungs start in the lungs, a few cases start in different pieces of the body and spread to the lungs. The two fundamental sorts of cellular breakdown in the lungs - little cell and non-little cell - develop and spread in various ways, and each type can be dealt with in an unexpected way.

Track 3:Developmental disorders

Developmental disorders are better called neurodevelopmental disorders. Neurodevelopmental disorders are neurologically-based conditions that can interfere with the acquisition, retention, or application of specific skills or sets of information. They may involve dysfunction in attention, memory, perception, language, problem-solving, or social interaction. These disorders may be mild and easily manageable with behavioral and educational interventions, or they may be more severe, and affected children may require more support.

Neurodevelopmental disorders include

Attention-deficit/hyperactivity disorder

Autism spectrum disorders

Learning disabilities, such as dyslexia and impairments in other academic areas

Intellectual disability

Track 4:Environmental &Occupational Lung Disease

Occupational and environmental lung disease patients benefit from the wide range of specialists at The Lung Center, including thoracic surgeons, oncologists, pulmonologists and imaging experts. This collaboration ensures comprehensive diagnosis and targeted treatment for patients.Any recommended surgery or procedure will be performed by an experienced, board-certified surgeon, in collaboration with the treatment team including nurses and physician assistants, all of whom specialize in taking care of patients with occupational and environmental lung diseases

Pulmonologists and thoracic surgeons who specialize in occupational and environmental lung health at the Brigham and Women’s Hospital (BWH) Lung Center provide comprehensive care for patients with occupational and environmental lung diseases.

Track 5:Mediastinal Disease

The mediastinum is the central compartment of the thoracic cavity that is located between the two lungs and between the breastbone and the spine. The mediastinum contains the trachea (windpipe), esophagus (swallowing tube), the heart and its veins and arteries, the thymus, nerves, fat, and lymph nodMediastinal diseases are conditions that arise from tissues in this cavity. They include cancerous tumors (thymomas, lymphomas, germ cell tumors, carcinoids) and noncancerous tumors (lipoma, teratoma), masses, enlarged lymph nodes, and cysts (bronchogenic, pericardial, esophageal). Mediastinal tumors are rare but due to their location can be serious. As they grow, they can cause pressure on the heart, lungs, esophagus, trachea, and spine.Our group of highly trained thoracic surgeons performs a range of procedures to treat mediastinal diseases most of which can be performed minimal Our thoracic surgeons work closely with UT Southwestern’s pulmonologistsoncologistsgastroenterologists, chest radiologists, and pathologists to deliver multidisciplinary comprehensive care – all in one location, and usually on the same day.

Track 6:Pulmonary Vascular Disease

Patients with pulmonary vascular disease may benefit from restoration of normal blood gases and alveolar gas composition, as alveolar hypoxia, arterial hypercarbia, and acidosis all increase pulmonary vascular tone. the pulmonary vascular disease carries some risks. Right atrial pressure, pulmonary arterial pressure, pulmonary capillary wedge pressure, systemic blood pressure, and mixed venous saturation should be routinely assessed. Cardiac output is determined by thermodilution or estimated with the modified Fick technique, but measurement rather than estimation of oxygen consumption is recommended. Pulmonary vascular resistance, in Woods units times body surface area, is calculated as mean pulmonary arterial pressure minus pulmonary capillary wedge pressure or left atrial pressure divided by cardiac output. Testing with a short-acting vasodilator allows detection of the remaining potential of reactivity of small pulmonary arteries and arterioles or demonstrates fixed resistance.

Track 7:Neoplasms

The body is made up of trillions of cells that grow, divide, and die in an orderly fashion. This process is tightly regulated and controlled by the DNA machinery within the cell. During childhood, the cells of the body rapidly divide; however, once adulthood is reached, cells generally only divide to replace worn-out and dying cells or to repair injured cells.

Neoplasia describes when these cells proliferate in an abnormal manner that is not coordinated with the surrounding tissue. These rogue cells, which are otherwise referred to as neoplastic cells, cannot be controlled in the way that normal cells can because they do not die when they should and they divide more quickly.

As this excessive growth persists, a lump or tumor that has no purpose or function in the body is eventually formed. This is referred to as a neoplasm and it may be non-cancerous (benign), pre-cancerous (pre-malignant), or cancerous (malignant)

Track 8:Lung Infection

Lung infections are some of the most common medical conditions in the world. Tens of millions of people have lung disease in the U.S. alone. Smoking, infections, and genes cause most lung diseases.

Your lungs are part of a complex system, expanding and relaxing thousands of times each day to bring in oxygen and send out carbon dioxide. Lung disease can happen when there are problems in any part of this system.

A lung infection occurs when a dangerous microbe, such as a bacterium or a virus, gets into the lungs and causes damage. The severity of a lung infection can range from mild to life-threatening.

Although most types of lung infections are treatable and most people recover, these infections are also very dangerous. This is especially the case for infants, older adults, and people with lung disease or a weak immune system.

Identifying the type of lung infection a person has is important for treating it. Although their symptoms may help with this, a person cannot self-diagnose their own lung infection. Also, life-threatening illnesses such as lung cancer may mimic the symptoms of certain lung infections, so it is important to contact a doctor.

Track 9:Lung Disease

Lung illness alludes to many kinds of sicknesses or issues that keep the lungs from working appropriately. Lung infection can influence respiratory capacity or the capacity to inhale, just as lung work, which is the way well the lungs work. There are numerous different lung sicknesses, a few of which are brought about by bacterial, viral, or parasitic diseases. Other lung sicknesses are identified with ecological elements, including asthma, mesothelioma, and carcinoma. The persistent lower respiratory ailment might be an assortment of conditions that has constant obstructive pneumonic sickness (COPD), emphysema, and bronchitis. Together, persistent lower respiratory illness is the main source of death in the United States. In other lung conditions, like lung fibrosis, scarring of the lung tissue, which can be brought about by different elements, and pneumonia, a bacterial or viral disease wherein the air sacs load up with liquid, the lungs have a decreased capacity to hold air. Cellular breakdown in the lungs might be a sickness brought about by strange cell development. Albeit most instances of cellular breakdown in the lungs start in the lungs, a few cases start in different pieces of the body and spread to the lungs. The two fundamental sorts of cellular breakdown in the lungs - little cell and non-little cell - develop and spread in various ways, and each type can be dealt with in an unexpected way.

Track 10:Critical Care

Pulmonary medicine may be a subspecialty of general medicine that focuses on the prevention, diagnosis, and treatment of conditions that affect the lungs and tract. Here are a number of the foremost common conditions that our pulmonologists diagnose and treat. Critical care may be a high-quality, peer-reviewed, international clinical medical journal. Critical Care aims to enhance the care of critically ill patients by acquiring, discussing, distributing, and promoting evidence-based information relevant to intensivists. Critical Care aims to supply a comprehensive overview of the medical care field.

Track 11:Pleural Disease

Pleurisy - an infection of the pleural cavity. Pleural effusion - the buildup of pleural fluid in the pleural cavity. Pneumothorax - the presence of air or gas in the pleural cavity. Hem thorax - the presence of blood in the pleural cavity. Many different conditions can cause pleural problems. Viral infection is the most common cause of pleurisy. The most common cause of pleural effusion is congestive heart failure. Lung diseases, like COPD, tuberculosis, and acute lung injury, cause pneumothorax. Injury to the chest is the most common cause of hem thorax. Treatment focuses on removing fluid, air, or blood from the pleural space, relieving symptoms, and treating the underlying condition.

Track 12:Diffuse Lung Disease

Diffuse lung disease refers to a large group of lung disorders that affect the interstitium, which is the connective tissue that forms the support structure of the alveoli (air sacs) of the lungs. Normally when you inhale, the air sacs fill with air and oxygen passes into the bloodstream. When you exhale, carbon dioxide that passed from the blood into the air sacs is expelled from the body. When interstitial lung disease is present, the lung is inflamed and stiff, preventing the air sacs from fully expanding. This limits both the delivery of oxygen to the bloodstream and the removal of carbon dioxide from the body. As the disease progresses, the interstitium thickens, which further impedes lung function

Track 13:Pulmonary Nuclear Medicine

the contribution made by nuclear imaging to the assessment, diagnosis, and monitoring of patients with respiratory disease. It focuses on several specific areas including the diagnosis of pulmonary embolism, the investigation of intrapulmonary infection and neoplasm, and the role of positron emission tomography (PET) scanning.

Track 14:Lung Anatomy &Development

Lungs are the major organs of the respiratory system and are divided into sections or lobes. The right lung has three lobes and is slightly larger than the left lung, which has two lobes. The lungs are separated by the mediastinum. This area contains the heart, trachea, esophagus, and many lymph nodes. The lung develops at about 4-6 weeks' gestation in humans as a ventral outpouching of the primitive foregut into the surrounding ventral mesenchyme. This structure is termed the laryngotracheal groove and it is the forerunner of the larynx and trachea

Track 15 : Advances in Respiratory Medicine

 Routine respiratory organ perform and digestion muscle testing are recommended in youths with fasciculus disorder (NMD), anyway these tests are bolstered non-intrusive deliberate manoeuvres, like the estimating of respiratory organ volumes and incomparable static weights, that youthful adolescents may not always have the capacity to perform. The finish of direct regular moves like a sniff or a hack, and along these lines the estimating of oesophageal and interior organ weights all through unconstrained breath will include significant information concerning the quality and perseverance of the digestion muscles in youthful adolescents. Perception digestion muscles in youths with NMD may improve comprehension of the clarification of NMD and along these lines the examination of infection seriousness. It will help and guide clinical administration and it will encourage the ID and decision of ideal completion focuses, likewise on the grounds that the most instructive Frameworks and patients for clinical preliminaries.

The global respiratory capsules market size will develop with the aid of USD 17.Sixty seven billion for the duration of 2018-2022. This enterprise research record presents a detailed analysis of the marketplace based on kind (bronchial asthma, persistent obstructive pulmonary sickness (COPD), allergic rhinitis, cystic fibrosis, idiopathic pulmonary fibrosis, and different breathing problems.

The growth in incidences and occurrence of respiratory problems is driving worldwide respiration tablets market. Several types of breathing illnesses consisting of COPD, bronchial asthma, and acute breathing infections are at the rise causing primary mortality and disorder burden on sufferers. Moreover, respiratory sicknesses account for greater than millions of deaths in growing nations with an excessive variety of instances stated for children. This created the want for management and treatment of breathing sicknesses, which in flip, drives the respiratory pills marketplace.

Currently, North America dominates the pulmonary drug shipping devices marketplace, and Asia represents the second-biggest regional market. Moreover, the Asian market is expected to register the best CAGR during the forecast length because of the unexpectedly developing geriatric populace, growing adoption of an unhealthy lifestyle, developing urbanization, publicity to smoke & chemical compounds, and the subsequent increase in the prevalence of COPD within the place.

 

Importance & Scope:

The scope of pulmonology practice includes compounding and dispensing medications, and it also related to more modern services like patient care, including clinical services, reviewing medications for safety and efficacy, and providing drug information.

This respiratory congress is the best platform that would help the pulmonologists and respiratory care professionals to get the insights and latest trends to improve the patients care. All the researchers working in the field of Pulmonology, Respiratory Medicine, Asthma, Pneumonia, emphysema, tuberculosis, COPD, lungs diseases, Lung Cancer, complicated chest infections and other allied fields will be of interest.

Recently, Economic recession is not affected to any drug industry. This is because demand of drugs will not suppress ever. Lot of new problems regarding health and sanitation are arising day by day. Lot of work is there for pharmacist to take care of public sector.

 

 Target Audience:

  • Pulmonary drug delivery devices and formulation manufacturers
  • Public and private physicians
  • Healthcare institutions (Medical data centers)
  • Research & clinical laboratories
  • Distributors and suppliers of pulmonary drug delivery devices
  • Health insurance companies
  • Market research and consulting firms
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneurs

Related Companies/Industries:

  • A Menarini Asia-Pacific Holdings Pte Ltd,
  • Ab Sciex (Distribution)
  • Abbott Laboratories (S) Pte Ltd,
  • Abbott Mfg Singapore Pte Ltd,
  • Abbvie Pte Ltd,
  • Acyx Enterprise
  • Advance Healthcare Pte Ltd,
  • Advanced Medi Mart,
  • Agila Specialties Global Pte Ltd,
  • Alcon Singapore Mfg Pte Ltd,
  • Allergen Singapore Pte Ltd,
  • Apex Pharma Marketing Pte Ltd,
  • Apotheca Marketing Pte Ltd,
  • Astonix Life Science (S) Pte Ltd,
  • Astrazeneca Singapore Pte Ltd,
  • Atlantic Pharmaceutical (S) Pte Ltd,
  • Aurum Medicare Pte Ltd,
  • Aventis Pharma Mfg Pte Ltd,
  • Ayuryoga Clinic of Ayurveda & Yoga Pte Ltd,
  • Bago Laboratories Pte Ltd,
  • Beacons Pharmaceuticals Pte Ltd,
  • Beecham Pharmaceuticals (Pte) Ltd,

Related Associations and Societies:

  • Philippine College of Chest Physicians
  • American Association for Respiratory Care
  •  Australian Lung Foundation
  •  Bangladesh Lung Foundation
  • British Thoracic Society
  • European Respiratory Society
  • Global Initiative for Obstructive Lung Disease
  • International Union Against Tuberculosis & Lung Disease
  • Korean Academy of Tuberculosis & Respiratory Diseases
  • World Association of Bronchology and Interventional Pulmonology
  • South African Thoracic Society

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 19-20, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View